相关实验视频

Updated: Jul 26, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

工艺开发和扩大Largazole的总合成,这是一个强大的I类希斯脱乙酶抑制剂

Qi-Yin Chen^1,2,3, Pravin R Chaturvedi³, Hendrik Luesch^1,2,3

¹Department of Medicinal Chemistry, University of Florida, Gainesville, Florida, USA.

Organic process research & development

|June 19, 2023

概括

研究人员开发了一种可扩展的合成拉加,一个强大的抗癌基因素脱乙酶 (HDAC) 抑制剂. 这个过程产生了十克的药物,为各种疾病提供了有前途的治疗剂.

科学领域:

药用化学医学化学
有机合成有机合成
药理学药理学是指药理学的学科.

背景情况:

基斯脱乙酶 (HDAC) 抑制剂在癌症治疗中至关重要.
拉加是一种强大的I类选择性HDAC抑制剂,具有治疗潜力.
可扩展的合成对于药物开发和临床应用至关重要.

研究的目的:

开发和优化一个可扩展的拉巴佐尔的总合成过程.
为进一步研究和潜在的治疗用途生产大量的拉加.
建立一个强大的合成路线,适合大规模制造.

主要方法:

修改和优化关键片段的合成路径和最终的拉加产品.
扩大规模的研究,重点关注反应条件和净化技术.
为了高效的大规模生产,过程开发.

主要成果:

成功扩大了拉加佐碎片和最终化合物的合成.
制造数百克碎片和十克拉扎的碎片.
在八个步骤中达到21%的总产量,HPLC纯度>95%的largazole.

结论:

开发的过程使得拉加佐的高效和可扩展的合成成为可能.
这一进步有助于进一步研究拉加作为抗癌剂以及其他基于转录重编程的疗法.
高纯度和产量证明了优化合成路线的稳定性.

关键词:

这是一种抗癌药物.组织脱乙酶 (HDAC) 抑制剂长沙长沙是一种过程化学过程化学可扩展的过程可扩展的过程.总合成总合成

更多相关视频

Scale-up Chemical Synthesis of Thermally-activated Delayed Fluorescence Emitters Based on the Dibenzothiophene-S,S-Dioxide Core

Scale-up Chemical Synthesis of Thermally-activated Delayed Fluorescence Emitters Based on the Dibenzothiophene-S,S-Dioxide Core

Published on: October 24, 2017

Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones

Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones

Published on: February 7, 2019

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...